Health insurers will not be covering the cost of a new obesity medication coming on to the market in Ireland. Mounjaro, a ...
As a result, it will be available only on private prescription at a cost of €215 or more a month. That equates to an annual ...
Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...
Hosted on MSN18h
'King Kong' of weight-loss drugs, Mounjaro, will be available in Ireland from next weekUse precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for MASH and cardiometabolic diseases.
Eli Lilly & Co. tapped the US investment-grade bond market on Monday to help finance its roughly $2.5 billion purchase of a ...
Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback